The FDA removed semaglutide from the official shortage list in February 2025, which narrowed the conditions under which broad compounding can continue, and the FDA has warned about fraudulent or unapproved GLP-1 products
Other long-term risks and considerations include: Gallbladder Problems: Some studies and pooled safety analyses indicate an increased risk of gallstones or cholecystitis, particularly with longer treatment durations
Higher doses of retatrutide reduced biomarkers of insulin resistance, including fasting insulin, fasting C-peptide and HOMA2-IR, by up to 50% or more from baseline
Improved Mental Focus : Regular injections can enhance brain function, boosting concentration and mental clarity
Dosages can vary significantly depending on factors such as individual body chemistry, cognitive goals, and the route of administration (e.g., oral vs
The health of the egg is largely determined by the quality of the follicular fluid surrounding it